122 related articles for article (PubMed ID: 11261296)
1. [C cell hyperplasia and medullary microcarcinomas of the thyroid].
Guyetant S; Saint-Andre JP
Ann Pathol; 2000; 20 Suppl():S39-44. PubMed ID: 11261296
[No Abstract] [Full Text] [Related]
2. Editorial review of "Malignant progression from C-cell hyperplasia to medullary thyroid carcinoma in 167 RET germline mutations".
Wilhelm S; Prinz RA
Surgery; 2004 Apr; 135(4):447-8. PubMed ID: 15041969
[No Abstract] [Full Text] [Related]
3. [Diagnosis and therapy of medullary thyroid carcinoma].
Obara T; Kanbe M; Iihara M; Yamaguchi K; Futami H
Nihon Naika Gakkai Zasshi; 1997 Jul; 86(7):1202-8. PubMed ID: 9379100
[No Abstract] [Full Text] [Related]
4. Surgical treatment of medullary carcinoma of the thyroid.
Favia G; Lumachi F
Tumori; 2001; 87(4):S49-51. PubMed ID: 11693822
[No Abstract] [Full Text] [Related]
5. Thyroid carcinoma: diagnostic and therapeutic approach; genetic background (review).
Lewinski A; Ferenc T; Sporny S; Jarzab B
Endocr Regul; 2000 Jun; 34(2):99-113. PubMed ID: 10991553
[No Abstract] [Full Text] [Related]
6. A novel germline point mutation, c.2304 G-->T, in codon 768 of the RET proto-oncogene in a patient with medullary thyroid carcinoma.
Antiñolo G; Marcos I; Fernández RM; Romero M; Borrego S
Am J Med Genet; 2002 Jun; 110(1):85-7. PubMed ID: 12116277
[No Abstract] [Full Text] [Related]
7. Familial medullary thyroid carcinoma with noncysteine ret mutations: phenotype-genotype relationship in a large series of patients.
Niccoli-Sire P; Murat A; Rohmer V; Franc S; Chabrier G; Baldet L; Maes B; Savagner F; Giraud S; Bezieau S; Kottler ML; Morange S; Conte-Devolx B;
J Clin Endocrinol Metab; 2001 Aug; 86(8):3746-53. PubMed ID: 11502806
[TBL] [Abstract][Full Text] [Related]
8. Recommendations for reporting C cell pathology of the thyroid.
Kaserer K; Scheuba C; Neuhold N; Weinhäusel A; Vierhapper H; Niederle B
Wien Klin Wochenschr; 2002 Apr; 114(7):274-8. PubMed ID: 12089863
[TBL] [Abstract][Full Text] [Related]
9. RET activation in medullary carcinomas.
Pierotti MA; Arighi E; Degl'innocenti D; Borrello MG
Cancer Treat Res; 2004; 122():389-415. PubMed ID: 16209058
[No Abstract] [Full Text] [Related]
10. Pathology forum: quiz case 1. Early medullary thyroid carcinoma (MTC), familial type, arising in a background of C-cell hyperplasia.
Parwani AV; Allan RW; Westra WH; Udelsman R; Ball DW; Argani P
Arch Otolaryngol Head Neck Surg; 2001 May; 127(5):594, 596-7. PubMed ID: 11346440
[No Abstract] [Full Text] [Related]
11. Familial medullary thyroid carcinoma and prominent corneal nerves associated with the germline V804M and V778I mutations on the same allele of RET.
Kasprzak L; Nolet S; Gaboury L; Pavia C; Villabona C; Rivera-Fillat F; Oriola J; Foulkes WD
J Med Genet; 2001 Nov; 38(11):784-7. PubMed ID: 11732489
[No Abstract] [Full Text] [Related]
12. Total thyroidectomy for hereditary medullary thyroid carcinoma 12 years after correction of Hirschsprung's disease.
Sasaki Y; Shimotake T; Go S; Iwai N
Eur J Surg; 2001 Jun; 167(6):467-9. PubMed ID: 11471675
[No Abstract] [Full Text] [Related]
13. Difference between familial and sporadic medullary thyroid carcinomas.
Mears L; Diaz-Cano SJ
Am J Surg Pathol; 2003 Feb; 27(2):266-7. PubMed ID: 12548176
[No Abstract] [Full Text] [Related]
14. [Endocrine surgery. Series 6: Alteration of RET proto-oncogene and clinical implication in medullary thyroid carcinoma. Genetic screening of family members at risk for inherited medullary thyroid carcinoma].
Kitamura Y; Shimizu K; Tanaka S
Nihon Ika Daigaku Zasshi; 1996 Jun; 63(3):228-32. PubMed ID: 8707923
[No Abstract] [Full Text] [Related]
15. Identification of a novel somatic mutation in the RET proto-oncogene in a patient with sporadic medullary thyroid carcinoma.
Matias-Guiu X; Lagarda E; Calaf M; Azpiroz A; De Leiva A; Prat J; Baiget M
Hum Mutat; 1997; 9(5):476. PubMed ID: 9143934
[No Abstract] [Full Text] [Related]
16. A new identified germline mutation of the RET proto-oncogene responsible for familial medullary thyroid carcinoma in co-existence with a hyperfunctioning autonomous nodule.
Maschek W; Pichler R; Rieger R; Weinhäusel A; Berg J
Clin Endocrinol (Oxf); 2002 Jun; 56(6):823. PubMed ID: 12072055
[No Abstract] [Full Text] [Related]
17. [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].
Sansó G; Domené HM; Iorcansky S; Barontini M
Medicina (B Aires); 1998; 58(2):179-84. PubMed ID: 9706252
[TBL] [Abstract][Full Text] [Related]
18. [Consequences of clinical genetic analysis of RET proto-oncogene].
Włoch J; Wygoda Z; Wiench M; Gubała E; Kula D; Oczko M; Lange D; Jarzab B
Wiad Lek; 2001; 54 Suppl 1():406-14. PubMed ID: 12182057
[TBL] [Abstract][Full Text] [Related]
19. Development of medullary thyroid carcinoma in transgenic mice expressing the RET protooncogene altered by a multiple endocrine neoplasia type 2A mutation.
Michiels FM; Chappuis S; Caillou B; Pasini A; Talbot M; Monier R; Lenoir GM; Feunteun J; Billaud M
Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3330-5. PubMed ID: 9096393
[TBL] [Abstract][Full Text] [Related]
20. RET proto-oncogene mutation in a mixed medullary-follicular thyroid carcinoma.
Orlandi F; Chiefari E; Caraci P; Mussa A; Gonzatto I; De Giuli P; Giuffrida D; Angeli A; Filetti S
J Endocrinol Invest; 2001 Jan; 24(1):51-5. PubMed ID: 11227733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
